Aprotinin protects platelets against the initial effect of cardiopulmonary bypass
- 1 May 1990
- journal article
- clinical trial
- Published by Elsevier BV in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 99 (5), 788-797
- https://doi.org/10.1016/s0022-5223(19)36893-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- PLATELET PRESERVATION BY APROTININ DURING CARDIOPULMONARY BYPASSThe Lancet, 1988
- Effects of Aprotinin on Hemostatic Mechanisms during Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1987
- EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERYThe Lancet, 1987
- The role of platelet membrane glycoproteins Ib and IIb‐IIIa in platelet adherence to human artery subendotheliumBritish Journal of Haematology, 1986
- Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac SurgeryNew England Journal of Medicine, 1986
- von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia.JCI Insight, 1986
- Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.JCI Insight, 1985
- ROLE OF VON WILLEBRAND FACTOR IN PLATELET ADHESION TO THE SUBENDOTHELIUMBritish Journal of Haematology, 1983
- The Effect of Prostaglandin E1 in Patients Undergoing Clinical Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1983
- Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel WallsNew England Journal of Medicine, 1979